Prime Medicine FDA clears PM647 IND
Prime Medicine said the U.S. FDA cleared its investigational new drug application for PM647 in alpha-1 antitrypsin deficiency.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.